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cardiomyocytes sense the rigidity of the
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from non-muscle and muscle myosin.
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stiffness and the level of non-muscle
myosin activity..
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Mechanical properties are cues for many biological
processes in health or disease. In the heart, changes
to the extracellular matrix composition and cross-
linking result in stiffening of the cellular microenvi-
ronment during development. Moreover, myocardial
infarction and cardiomyopathies lead to fibrosis
and a stiffer environment, affecting cardiomyocyte
behavior. Here, we identify that single cardiomyocyte
adhesions sense simultaneous (fast oscillating) car-
diac and (slow) non-muscle myosin contractions.
Together, these lead to oscillating tension on the
mechanosensitive adaptor protein talin on sub-
strates with a stiffness of healthy adult heart tissue,
compared with no tension on embryonic heart stiff-
ness and continuous stretching on fibrotic stiffness.
Moreover, we show that activation of PKC leads to
the induction of cardiomyocyte hypertrophy in a stiff-
ness-dependent way, through activation of non-
muscle myosin. Finally, PKC and non-muscle myosin
are upregulated at the costameres in heart disease,
indicating aberrant mechanosensing as a contrib-
uting factor to long-term remodeling and heart
failure.
INTRODUCTION
Cells in the myocardium are exposed to different types of forces,
including hemodynamic pressure, stretching forces through the
cardiomyocyte contraction, as well as passive elasticity from the
extracellular matrix. All of these are subject to change during
development and disease. In particular, the composition of the
extracellular matrix shows spatial and temporal changes during
cardiac development, including differential expression of matrix
proteases, proteoglycans, glycosaminoglycans, and glycopro-326 Developmental Cell 44, 326–336, February 5, 2018 ª 2018 The A
This is an open access article under the CC BY license (http://creativeteins, such as collagens, fibronectin, or laminin (Rienks et al.,
2014; Lockhart et al., 2011). Together these changes result in
an increase of cardiac stiffness from the low kilopascal range
in the embryonic heart to10 kPa in the adult heart (during dias-
tole) (Huyer et al., 2015; Majkut et al., 2013; Jacot et al., 2010).
On the other hand, cardiac fibrosis results in increased expres-
sion and cross-linking of extracellular matrix components,
thereby again changing the mechanical landscape, and rigidities
above 100 kPa have been reported for fibrotic tissue (Wei et al.,
2015; Szibor et al., 2014; Jacot et al., 2010; Soufen et al., 2008;
Bishop and Laurent, 1995). Over the past decade there has been
accumulating evidence that a wide range of different cell types
can probe and react to changes in rigidity (Iskratsch et al.,
2014). Also, several studies have investigated the role of matrix
stiffness in primary or stem cell derived cardiomyocytes. While
the contractile stress increases with the elastic modulus of
the matrix, myofibrillar maturity and contractile work show a
biphasic response and are highest on 10 kPa hydrogels
(McCain et al., 2014; Hersch et al., 2013; Hazeltine et al., 2012;
Rodriguez et al., 2011; Engler et al., 2008; Jacot et al., 2008).
This indicates that the expression of myofibrillar proteins, as
well as the assembly and maturation of myofibrils, respond to
stiffness. However, it is still unknown how cardiomyocytes
measure the rigidity to influence gene expression pattern or
myofibrillogenesis.
To investigate this, we use here nanopillars, which have been
an invaluable tool for mechanotransduction studies in various
cell types, mainly because of their high spatial and temporal res-
olution, compared with conventional traction force microscopy
(Meacci et al., 2016; Wolfenson et al., 2016; Tabdanov et al.,
2015; Iskratsch et al., 2014; Iskratsch et al., 2013b). Also, in
contrast with micropillars, they have no obvious effects on
cell morphology or adhesion formation (Ghassemi et al., 2012).
For our study, we combine nanopillars with flat silicon gels
with defined rigidity as a screening platform and for complemen-
tary experiments, including Förster resonance energy transfer
(FRET) tension sensor measurements. In this way, we identify
that cardiomyocytes sense a combination of slow non-muscle
myosin and fast muscle myosin contractions that result inuthors. Published by Elsevier Inc.
commons.org/licenses/by/4.0/).
Figure 1. NRC Spreading on Pillars Indicates Repeated Probing of Environment
Freshly isolated neonatal rat cardiomyocytes (NRCs) were plated on PDMS pillars and imaged overnight every hour, after an initial spreading period (4 hr).
(A) To distinguish between systole and diastole, three consecutive frames, with 200 ms delay, were taken at each time point and cells in diastole were stacked
together.
(B) Example cell outlines, color coded for each time point as indicated in the color lookup table.
(C) Example force maps for NRCs on 1.3- or 1.7-mm-tall pillars indicate continuous probing of the environment.
(D) NRCs spread faster on stiff pillar surfaces (0.8 and 1.3 mm). Error bars: SEM.
(E and F) Analysis of pillar displacements (E, N > 100 pillars per cell and >12 cells per condition, displayed as average per cell) indicate a big jump in pillar
displacements between the 1.3 and 1.7 mm pillars whereby the force remains constant in this stiffness range (F). Error bars: mean ± SD (E, F). ****p < 0.0001;
ns, not significant; p values from ANOVA and Tukey correction for multiple comparisons.
See also Figures S1–S3; Movies S1, S2, and S3.oscillating stretching of the mechanosensitive protein talin on
physiological substrate rigidities but continuous stretching on
fibrotic stiffness. Moreover, we find that activation of PKC results
in alteration of rigidity sensing via the modulation of non-muscle
myosin contractility. Importantly, upregulation of PKC and non-
muscle myosin activity is also evident in disease models for
myocardial infarction (MI) and dilated cardiomyopathy even in
non-fibrotic areas. Therefore, we find that cardiomyocyte me-
chanosignaling is affected in heart disease through altered stiff-
ness, as well as humoral factors.
RESULTS
Cardiomyocytes Use Non-myofibrillar Contractions to
Apply Tension on the Environment during Spreading
Previous studies have highlighted the effect of extracellular
matrix stiffness on the myofibrillar organization and contractile
properties. To identify how cardiomyocytes sense the mechani-
cal properties of their environment, we first plated freshly iso-lated neonatal rat cardiomyocytes (NRCs) on fibronectin coated,
quantum dot labeled polydimethylsiloxane (PDMS) nanopillar
arrays with a stiffness of 1, 3, 6, and 21 pN/nm (or a calculated
equivalent elastic modulus of 4, 10, 22, and 78 kPa) and followed
them during spreading. Initial observations indicated the
presence of spontaneous contractions, typically lasting for
200 ms, and additional forces at the cell edge with slower dy-
namics, overlapping with a staining for active non-muscle
myosin light chain (further referred to here as non-myofibrillar
contractions; Figure S1 and Movie S1). To analyze the magni-
tude and localization of the non-myofibrillar forces during
spreading, we took three subsequent frames (separated by
200 ms) of the quantum dot labeled pillars at each time point
and stacked together images of the cells in diastole (Figure 1A).
Comparable with previous studies, we found larger cell areas,
lower circularity, and faster spreading on stiffer matrices (Figures
1B, 1D, and S2A). Non-myofibrillar forces were limited to the cell
edge and the individual pillars were pulled by the cardiomyo-
cytes for durations between 1 and 2 hr on all pillar dimensionsDevelopmental Cell 44, 326–336, February 5, 2018 327
Figure 2. Multi-rigidity Assay to Identify Inducers of Rigidity Sensing
(A) NRCs were plated on a multiwell plate with four different rigidities, serum starved, and treated with IGF-1, phenylephrine (PE), PMA, TGFb1, or angiotensin II
(AT2) for 48 hr.
(B and C) Cells were stained with phalloidin and a-actinin (B) and analyzed with cell profiler (size, shape, intensity) and ImageJ (alignment, see also Figure S3) (C).
Boxplot: Tukey.
(D) Depending on the response on different rigidities the stimuli can be grouped into those that act independent of rigidity (I), upstream of rigidity sensing (II), or
show no significant change over control (III).
(E and F) PKC inhibition with BIS I results in cell areas (F) and a-actinin staining (E) comparable with control cells cultured on soft surfaces. N > 240 cells from three
repeats for all conditions.
Error bars: SD. *p < 0.05; **p < 0.01; ***p < 0.001; ns, not significant; p values from ANOVA and Tukey correction for multiple comparisons. See also Figure S4.(Figures 1C, S2B–S2D and Movies S2 and S3). This indicated
that cells were continuously probing their environment, but the
speed of cell area expansion depended on the stiffness.
Because the forces were only applied at the cell edge, there
was no overall increase in traction stress (Figure S2E). Analysis
of the pillar displacements and resulting forces showed a non-
linear relationship between stiffness and displacement with a
big jump between 3 and 6 pN/nm pillar stiffness, equivalent to
elastic moduli between 10 and 22 kPa (Figures 1E, 1F, and
S2F–S2H) and approximately the range of rigidities that were
previously reported for healthy adult heart tissue (Huyer et al.,
2015; Majkut et al., 2013; Jacot et al., 2010). This surprising
result indicated an intrinsic regulation of force generation or
signaling that is pivotal for cardiomyocyte rigidity sensing.
PKC Activation Induces Stiffness-Dependent
Cardiomyocyte Maturation
In fibrotic heart tissue, cardiomyocytes are exposed to abnormal
matrix stiffness as well as cytokine and neurohumoral stimuli,
some of which can also activate pathways that induce expansion
of the cell area and the myofibrillar network in cardiomyocytes in
culture (insulin growth factor 1 [IGF-1], transforming growth
factor b1 [TGF-b1]). Similarly, activation of cardiomyocyte hyper-
trophy was reported after treatment with adrenergic agonists
or after phorbol-ester-mediated activation of PKC isozymes
(Watkins et al., 2012; Munoz et al., 2009; Vijayan et al., 2004;
Braz et al., 2002; Schultz Jel et al., 2002; Taylor et al., 2000).328 Developmental Cell 44, 326–336, February 5, 2018We aimed to identify reagents that activate myofibril formation
in a rigidity-dependent way to allow controlled induction of rigid-
ity sensing and detailed study of downstream effects with rele-
vance for the in vivo situation. For this we plated cardiomyocytes
on flat PDMS surfaces with defined stiffness, covering the stiff-
ness range from the embryonic to the fibrotic heart stiffness
(1, 6, 20, and 130 kPa; Figure 2A). To test the suitability of the sur-
faces for cardiomyocyte culture, we first measured contractile
properties in high-speed movies (>200 frames per second
[fps]) using GFP-tagged a-actinin as a marker for the Z-disc po-
sitions, from which we then extracted the extent and velocity of
sarcomeric shortening (Figure S3). As expected, cells were con-
tracting to a larger extent on soft surfaces (Figures S3A–S3G).
Moreover, sarcomeres shortened faster on soft PDMS (Fig-
ure S3H), in agreement with a load/velocity relationship typical
for muscle (Hill, 1938). Having confirmed the functionality of
the cardiomyocytes on all stiffnesses, we next plated NRCs on
multi-rigidity multiwell plates, serum starved the cells, and
treated themwith a range of reagents (phenylephrine [PE], angio-
tensin [AT], phorbol 12-myristate 13-acetate [PMA], IGF-1,
TGF-b1) that were previously reported to induce cardiomyocyte
hypertrophy (Figure 2A) (Watkins et al., 2012; Munoz et al., 2009;
Vijayan et al., 2004; Braz et al., 2002; Schultz Jel et al., 2002; Tay-
lor et al., 2000). After 48 hr of treatment, cells were fixed; stained
for a-actinin and F-actin; and analyzed for cell area, staining in-
tensity, and myofibril alignment (Figures 2A–2D and S4). Using
this approach, we could identify reagents that were inducing
Figure 3. Activation of Src, Non-muscle Myosin, and FHOD1 after PMA Treatment
(A and B) PMA treatment activates cell expansion for several hours. (A) Frames from a bright field movie of an NRC on stiff pillars, whereby pillars were filtered out
with a bandpass filter during post processing to enhance visibility of the cell. See also Movie S4. (B) Quantification of relative area change of n = 20 car-
diomyocytes each (PMA treated and serum-starved control) from differential interference contrast movies on fibronectin coated coverslip dishes.
(C–G) PKCa and PKCd are activated after PMA treatment. SFK and PKCd Y311 phosphorylation, associated with increased activity, are strongly enhanced (C);
quantified in (E) from n = 5, 3, 4, and 4 repeats for PKCa, PKCd Ser643, PKCd Y311, and pSFK, respectively. p values from unpaired t tests. (D) PMA treatment
results in higher levels of FHOD1 and non-muscle myosin activity; quantified in (F) from n = 4 repeats. (G) PMA treatment also enhances localization of active
FHOD1 (D, top) and non-muscle myosin light chain (D, middle, bottom) to the cell edge. Cells were counter stained with anti-a-actinin (top), anti-non-muscle
myosin 2B (middle), or transfected with non-muscle myosin 2B-mApple.
(H) Cardiomyocytes were filmed at 10 fps on 1.7-mm-high pillars (k = 3 pN/nm) and pillar displacements were analyzed in diastole and peak systole.
PMA treatment increases tension in diastole but not contractile forces. Diastolic tension returns to baseline levels after BIS I or PP2 treatment to inhibit PKC or Src.
N > 13 cells with >100 pillars analyzed per cell for all conditions. Boxplot: Tukey.
*p < 0.05; **p < 0.01; ***p < 0.001; ns, not significant; p values from ANOVA and Tukey correction for multiple comparisons. See also Figures S5–S7; Movie S4.cardiomyocyte hypertrophy independently of stiffness (PE,
IGF-1), only on stiff (PMA), or on neither stiff nor soft surfaces
(AT, TGF-b1) (Figures 2D and S4B). Because PMA was the
only reagent inducing cardiomyocyte hypertrophy in a stiff-
ness-dependent way and thus acting upstream of rigidity
sensing, we next tested the effect of PKC inhibition with bisindo-
lylmaleimide (BIS) II and I on cardiomyocyte phenotypes on
different surfaces. Indeed, both BIS II (not shown) and BIS I abol-
ished rigidity-dependent differences in cardiomyocyte pheno-
types. The cell morphology and a-actinin staining intensity in
BIS I-treated cells on soft and stiff surfaces were comparable
with control cells on soft surfaces, thus confirming an involve-
ment of PKC in cardiomyocyte rigidity sensing (Figures 2E
and 2F).
PMA Induces Activation of Non-myofibrillar Contractility
and Rapid Cell Area Expansion on Stiff Surfaces
We next analyzed the immediate response of cardiomyocytes to
PMA treatment. On stiff surfaces, NRCs immediately formed
protrusions and expanded the cell surface area over the timecourse of observation (Figures 3A and 3B and Movie S4). West-
ern blot analysis indicated activation of PKCa and PKCd (Figures
3C and 3E). It is noteworthy that, in line with previous reports
(Miranti et al., 1999), we found a reduction in PKCa and phos-
pho-PKC (pan and a/b1) levels after 3 hr and 24 hr (data not
shown), indicating that PKC activation was the initial trigger but
was dispensable for the long-term effects.
PKC is known to translocate to the membrane after integrin
activation and PMA treatment, where it is activated. At the cell
edge, its targets include several focal adhesion proteins as
well as the non-receptor tyrosine kinase Src (through PTPa)
(Brandt et al., 2003; Keenan and Kelleher, 1998). In agreement
with this, we also detected rapid phosphorylation of PKCd at
an Src-dependent phosphorylation site (Y311), which is associ-
ated with the regulation of activity as well as substrate specificity
and indicated a feedback mechanism (Rybin et al., 2008). This
feedback mechanism was confirmed when we probed for
changes to activity of Src depending on stiffness and PMA treat-
ment. Here we found strong activation of Src and/or related
kinases with a phospho-Src family kinase antibody (SFK) afterDevelopmental Cell 44, 326–336, February 5, 2018 329
PMA treatment (Figure 3C). Moreover, during cardiomyocyte
spreading, we found localization of active Src close to focal ad-
hesions, where it was partially overlappingwith a-actinin and vin-
culin staining pattern on stiff, but not soft, surfaces (Figures S5A
and S5B). The localization of active Src close to the cell edgewas
lost after BIS treatment, confirming activation of Src downstream
of PKC (Figure S5A). Stiffness-dependent differences in cell area
and a-actinin staining intensity were abolished after Src inhibi-
tion with PP2 in agreement with a role for Src during cardiomyo-
cyte rigidity sensing (Figure S5C).
It is noteworthy that, on the western blots, we did not detect
stiffness-dependent differences in PKCa or Src activation in
steady state (after serum starvation) or after PMA treatment
and only a slightly higher PKCd activity on stiff compared with
soft surfaces in the serum-starved controls (Figure 3E). There-
fore, our data show that PMA treatment leads to full activation
of PKC on all stiffnesses, suggesting that rigidity sensing occurs
downstream of PKC and Src.
Src activates actin assembly by regulating the localization and
downstream activation of FHOD1, which is a prominent formin
family protein in cardiomyocytes (Al Haj et al., 2015; Dwyer
et al., 2014; Iskratsch et al., 2013b). Moreover, it is known to
regulate activation of non-muscle myosin light chain through
modulating the activity of ROCKII and MLCK (Shen et al.,
2015; Lee et al., 2010; Birukov et al., 2001). Non-muscle myosin
IIB heavy chain was present in stress-fiber-like structures in
cardiomyocytes before and after PMA treatment (Figure 3G,
middle, anti-nmM2B; bottom, transfected with nmM2B-apple).
However, we found elevated levels of phosphorylated (active)
non-muscle myosin (pMLC T18/S19), as well as FHOD1, after
PMA treatment (Figures 3D and 3F) and increased activity of
these proteins at the cell edge (pMLC T18/S19 and pMLC S19
as well as pFHOD1; Figures 3G, S1, and S6). Treatment of
cardiomyocytes with the L-type calcium channel blocker
verapamil immediately stopped myofibrillar contractions, but ri-
gidity-dependent differences in cell area and a-actinin staining
intensity were only slightly reduced. Blebbistatin, in contrast,
completely abolished the differences, indicating that non-myofi-
brillar contractility is required for rigidity sensing (Figure S5D).
Therefore, we hypothesized that Src can activate non-muscle
myosin force generation, especially at the cell edge, to regulate
rigidity sensing. To test this, we tookmovies of contracting NRCs
(10 fps) on PDMS pillars (k = 3 pN/nm) after 30 min of PMA treat-
ment to resolve the myofibrillar contraction (Figure 3H). From the
data we extracted the displacement during diastole, relative dif-
ference between systole and diastole, as well as peak systolic
displacement, compared with the pillars in the original position
after removal of the cells with trypsin. Here we found a significant
increase in diastolic pillar displacements after PMA treatment
that returned to the baseline level after concomitant treatment
with BIS I or PP2, but we found no difference in the myofibrillar
contraction strength itself (Figure 3H). Acute treatment with
verapamil reduced the resting tension by 15% (Figures S7A
and S7B). Because verapamil blocks L-type (which are respon-
sible for excitation-contraction coupling) as well as T-type chan-
nels (which are expressed in neonatal but not adult ventricular
cardiomyocytes and fine-tune basal calcium levels) (Leuranguer
et al., 2000; Nargeot, 2000; Sipido et al., 1998; Cai et al., 1997;
Enyeart et al., 1993), the reduction in resting tension was likely330 Developmental Cell 44, 326–336, February 5, 2018due to altered diastolic calcium levels downstream of the latter.
This therefore indicates a contribution from Ca2+-sensitive ele-
ments, such as the titin N2B or PEVK domains, to the tension
observed on the pillars (Fujita et al., 2004; Lahmers et al.,
2004; Labeit et al., 2003; Linke et al., 2002). Also, in support of
a role for titin, the tension was reduced to the largest extent on
pillars that were contracted during systole, suggesting these
were indeed myofibrillar attachment sites (Figure S7A).
Nevertheless, large contributions to the diastolic tension were
insensitive to the verapamil treatment. This was especially the
case at sites close to the cell edge (Figure S7A, blue circles),
where we found the highest activity of non-muscle myosin (Fig-
ures 3G and S1). Indeed, both active pFHOD1 and pMLC were
located close to sites of large pillar displacements (peaking
about 1 mm inward of the original pillar center) and significantly
more enriched on stiff than on soft pillars (Figures S1 and S6).
Therefore, our data indicate that PKC enhances the non-myofi-
brillar contractility at the cell edge through activation of Src,
FHOD1, and non-muscle myosin.
Talin Is Cyclically Stretched in Cardiomyocytes on
Physiological Stiffness but Continuously Stretched on
Fibrotic Stiffness
Because our data indicated a modification of the force produc-
tion at the cell edge, we proceeded to a detailed analysis of
cardiomyocyte forces using nanopillar arrays with different
dimensions. In diastole, we again detected a sharp jump in pillar
displacements between 6 and 3 pN/nm pillar stiffness from 47 ±
4 to 104 ± 21 nm, while the force remained constant (291 ± 27
versus 311 ± 60 pN, mean ± SD; Figure 4A). A similar jump
in displacement between 6 and 3 pN/nm pillar stiffness was
observed during systole (from 119 ± 13 to 229 ± 51 nm) but,
unlike during diastole, we detected a further increase of dis-
placements on the softest pillars (275 ± 47 nm on 1 pN/nm stiff
pillars).
The displacement of the pillars is a function of the exerted
forces (in this casemyofibrillar and non-myofibrillar); the stiffness
of the pillars; as well as the stiffness of the integrins and adaptors
and the breakage force of the respective bonds (Roca-Cusachs
et al., 2012). Thereby the softest element will experience the
greatest strain (inversely proportional to its stiffness compared
with the stiffness of the other elements). Thus, our data sug-
gested that while on 1 pN/nm pillars the pillars will be deformed
to the largest extent, mechanosensitive adaptor proteins such as
talin (Roca-Cusachs et al., 2012; del Rio et al., 2009) could be
deformed proportionally and therefore buffer a part of the load
(Elosegui-Artola et al., 2014). Effects of adhesion reinforcement
will further enhance the integrin-cytoskeleton bond strength
and enable higher forces on high stiffness (Elosegui-Artola
et al., 2014; Chan and Odde, 2008).
Compared with non-muscle adhesions, which experience
force with a single loading rate from attached actin stress fibers,
we find that cardiomyocyte adhesions experience overlapping
slow non-myofibrillar forces and fast myofibrillar forces that
result in pillar displacements of >1 mm/s. Therefore, our data
could indicate proportionally stronger stretching of mechano-
sensitive adaptor proteins during the myofibrillar contractions.
Several mechanosensitive proteins have been reported so far,
including titin, p130Cas, vinculin, and talin (Zhou et al., 2015;
Figure 4. Mechanosensitive Proteins Are Cyclically Strained on Physiological Stiffness
(A) Analysis of pillar displacement on different pillar dimensions in systole and diastole. High pillars (2.3 mm) are significantly pulled further in peak systole, while
2.3- and 1.7-mm-tall pillars are being pulled to the same displacement during diastole, indicating cyclic stretching of (mechanosensitive) intracellular elements
(green circle). No change is observed between 0.8- and 1.3-mm-tall pillars, suggesting constitutive stretching of intracellular elements (red circle). Error bars: SD.
N > 12 cells with >100 pillars analyzed per cell for all conditions.
(B) Comparison of NRC cell edge movements after thresholding (as indicator of contractile state) and RFP/GFP ratio of a talin-TS or control sensor (CS) at
adhesions indicates cyclic loss of FRET (i.e., increase of tension) together with the contractions that are absent with the CS.
(C) Pearson coefficient was calculated for the normalized ratiometric signal (average of all adhesions) and the normalized cell edge position (see Figure S5C) for
the tension sensor on different stiffness as well as the CS.
(D) Comparison of the RFP/GFP ratio during diastole and peak systole (see Figure S5C), averaged over all contractions during the movie. Boxplots: Tukey;
N > 12 cells.
(E) Based on our data, we propose that cardiomyocytes sense the matrix rigidity using non-muscle and muscle myosin contractions, which work in series. On
physiological stiffness, this will cause cyclic stretching of mechanosensitive proteins, such as talin. Increased stiffness, or enhanced non-muscle myosin activity,
will result in a loss of cyclic mechanosignals. ECM, extracellular matrix.
*p < 0.05; **p < 0.01; ****p < 0.0001; ns, not significant; p values from ANOVA and Tukey correction for multiple comparisons. See also Figure S8.Linke, 2008; Puchner et al., 2008; Sawada et al., 2006). Talin is an
adaptor protein that directly links integrins with the actin cyto-
skeleton and stretching of talin by >100 nm has been demon-
strated in silico, in vitro, and in vivo (Yao et al., 2016; Margadant
et al., 2011). A talin molecular tension sensor (talin-TS) using the
flagelliform elastic domain with a dynamic force range of <6 pN,
which is insensitive to endogenous talin, indicated higher tension
on stiff than on soft surfaces in a range of different cells (Kumar
et al., 2016), although a subset of talin molecules experienced
forces of >7 pN (Austen et al., 2015). Dynamic talin stretching
opens cryptic binding sites for vinculin to allow adhesion rein-
forcement and mechanosensing (Kumar et al., 2016; Margadant
et al., 2011; del Rio et al., 2009). Because our data indicated
stronger enrichment of vinculin at stiff compared with soft pillars
(Figure S6), we hypothesized that talin stretching could be a key
factor in cardiomyocyte rigidity sensing.
The unfolding of the R3 domain, the initial mechanosensor
domain harboring vinculin binding sites, occurs at forces below5 pN (Yao et al., 2016). Therefore, we tested whether we could
detect differences in talin tension in cardiomyocytes on sub-
strates of different stiffnesses, using the talin-TS with the <6
pN elastic flagelliform domain (Kumar et al., 2016). Measuring
this sensor in fixed cells using a confocal microscope with spec-
tral detector to record simultaneously donor and acceptor fluo-
rescence after donor excitation, we could indeed detect a
decrease of FRET (i.e., an increase of tension) with increasing
stiffness (Figures S8A and S8B). To analyze the tension on talin
dynamically we next recorded movies of adhesions at 40 Hz
and compared the cell edge movements to track the myofibrillar
contractions with changes to FRET ratios at adhesions (Figures
4B–4D and S8C).
To quantify the differences, we calculated the Pearson corre-
lation coefficient, as well as the ratio of red fluorescent protein
(RFP)/GFP during diastole compared with the following systole
(Figure S8C) and calculated the average between all con-
tractions over the length of the movie (1,000 frames). OnDevelopmental Cell 44, 326–336, February 5, 2018 331
Figure 5. Elevated PKCd and Non-muscle Myosin Activity after Myocardial Infarction and in Dilated Cardiomyopathy
Mouse hearts, 4 weeks after myocardial infarction (MI) or sham-operated mice (A–C) were stained with antibodies against PKCa, PKCd, pMLC, a-actinin, or
vinculin. White boxes indicate the regions of the close ups, shown on the right hand side of the figure panels. White lines indicate the regions for the line scan.
(A) PKCa co-localizes with a-actinin in sham as well as in MI samples.
(B) PKCd activity is elevated at the Z disc in MI samples but only diffusely localized in sham-operated mice.
(C) Similarly, pMLC staining intensity is found in striations that partially overlap with vinculin or a-actinin (not shown) and likely localize between Z disc and
costameres.
(D) Cartoon indicating the localization of the relevant molecules and activating pathways. Briefly, PKC activates Src, which again modulates PKC activity through
tyrosine phosphorylation. Src activation in turn leads to alteration of non-myofibrillar tension through FHOD1 and non-muscle myosin. Src also associate with
b1-integrin tails, resulting in its activation. Activating pathways, which are discussed in the main text and are not part of the current study but have been published
previously, are indicated in yellow. Focal adhesions and stress-fiber-like structures as found in cultured cardiomyocytes are indicated on the left and costameres
on the right. See also Figure S9.intermediate stiffness (6 kPa), we detected comparably high cor-
relation, as well as 35% higher tension on the sensor in systole
versus diastole. Both the tension ratio and correlation were lower
on 20 kPa surfaces and there were no detectable differences be-
tween the control sensor and the tension sensor on 1 kPa or
130 kPa surfaces. Also, both measurements were reduced after
treatment with BIS I or PP2 (Figures S8D and S8E), confirming
that cyclical stretching of talin is regulated downstream of PKC
and Src activity. Therefore, our data indicated that non-muscle
and muscle myosin derived forces together result in cyclical
stretching of talin during myofibrillar contractions on physiolog-
ical stiffness but continuous extension on fibrotic stiffness (see
model in Figure 4E).
PKCd and Non-muscle Myosin Activity Are Enhanced in
Cardiac Disease
Cardiac fibrosis is one of the key responses to heart diseases
from MI to cardiomyopathies. It includes scar tissue formation
in the infarcted region, perivascular and interstitial fibrosis in
non-infarcted regions in cases of MI, perivascular and interstitial
fibrosis in cardiomyopathies, as well as replacement or focal332 Developmental Cell 44, 326–336, February 5, 2018fibrosis in the late phase of remodeling leading to heart failure.
While fibrosis helps to counteract rupture, aneurysm, or dilation,
it also leads to a loss of elasticity of the heart and elastic moduli
of >100 kPa have been reported for fibrotic tissue. Interestingly,
elevated PKC levels have been reported for bothMI (PKCa and d)
as well as dilated cardiomyopathy (PKCa) (Lange et al., 2016;
Wang et al., 2003b; Simonis et al., 2002).
In support of this, we found PKCd and PKCa in a striated
pattern, partially overlapping with a-actinin, in infarcted mouse
hearts (Figures 5A and 5B). This indicated localization to integrin
adhesion sites at costameres in agreement with reported inter-
actions of PKC and integrins (Chae et al., 2010; Disatnik and
Rando, 1999; Haller et al., 1998). In the sham-operated controls
this pattern was less pronounced for PKCa and absent in case of
PKCd. Similarly, phosphorylated non-muscle myosin light chain
was present in infarcted hearts at a localization that was partially
overlapping with a-actinin (not shown) and co-staining with vin-
culin confirmed strong costameric localization, which again was
absent in the sham-operated mice (Figure 5C). While in the sham
hearts, a faint striated pattern could be observed, the staining
was not overlapping, but rather displayed double peaks in
between the vinculin striations (Figure 5C, line scans) and there-
forewas likely caused by cross-reactivity of the antibodywith the
cardiac myosin light chain at the A bands. A comparable result
was also obtained when we examined left ventricles of the
MLP knockout mouse, a widely studiedmodel for dilated cardio-
myopathy (Figure S9) (Arber et al., 1997). Non-muscle myosin
was again prominent at the costameres and additionally also
the intercalated disc but was only detected in a diffuse cyto-
plasmic staining or alternating with the a-actinin staining pattern.
Therefore, we find that signaling pathways leading to the activa-
tion of rigidity sensing could also play a role in cardiac disease
models wherewe detect enhanced PKC and non-musclemyosin
activity at integrin adhesion sites. Together our results demon-
strate a finely tuned system that is sensitive toward both in-
creases in the stiffness of the environment as well as humoral
factors that lead to elevated non-muscle myosin contractility.
DISCUSSION
Using a combination of nanopillars and flat surfaces with defined
stiffness, we identify here a mechanism for cardiomyocyte rigid-
ity sensing that relies on a combination of non-muscle myosin
and muscle myosin contractions and can be activated by PKC
signaling. PKC activates Src, which in a feedback mechanism
modulates PKC activity through tyrosine phosphorylation. Src
activation in turn leads to alteration of non-myofibrillar tension
through FHOD1 and non-musclemyosin. This affects the tension
on talin, thereby modulating the mechanical response by recruit-
ment of vinculin to cryptic binding sites, which enhances the
stability of the integrin-talin-actin link (del Rio et al., 2009). It is
noteworthy that the effect on the stability of the talin-integrin
interaction will likely feedback into Src activity, since Src is
known to associate with b1-integrin tails, resulting in its acti-
vation, possibly through dephosphorylation by PTP-1B (Das
et al., 2014) (see also cartoon in Figure 5D).
Importantly, our data reveal three discrete regimes of mecha-
notransduction, with either unstretched, cyclically stretched, or
constitutively stretched mechanosensors. These regimes cover
the stiffness of the fetal, adult, and fibrotic heart, respectively,
and are regulated by the tension generated by non-muscle
myosin (Huyer et al., 2015; Majkut et al., 2013; Jacot et al.,
2010; Engler et al., 2008).
Previous work has highlighted the importance of myofibrillar
tension (especially the mechanical relaxation) for cardiac health,
whereby the integrated tension over the myofibrillar contraction
can be used to predict whether sarcomeric mutations lead to
concentric or eccentric hypertrophy (Davis et al., 2016). Here,
we identify a role for non-muscle myosin activity, which leads
to enhanced baseline tension in fibrotic hearts after MI or in
dilated cardiomyopathy. The increased non-myofibrillar tension
acts together with the increased passive elasticity of the fibrotic
heart to shift oscillating to constitutive mechanosignaling in heart
disease. Our results are in broad agreement with previous
studies from primary and stem cell derived cardiomyocytes, re-
porting higher stresses with increasing stiffness (McCain et al.,
2014; Hersch et al., 2013; Hazeltine et al., 2012; Rodriguez
et al., 2011; Jacot et al., 2008). However, the discovery of the
different types ofmechanotransduction, enabled by the high res-
olution of the nanopillars, as well as the range of stiffness chosenfor this study have important implications on our understanding
of cardiac disease pathways. The non-muscle myosin forces
are expected to further modify the tension integral, reported by
Davis et al. (2016), but future work will need to analyze the me-
chanosignaling response in relevant eccentric or concentric
disease models in detail.
Non-muscle myosin is present in cardiomyocytes in two
isoforms (NM II-B and C), where it was found at the Z discs
(NM II-B) and intercalated discs (NM II-B and C) (Ma and Adel-
stein, 2012; Takeda et al., 2000; Tullio et al., 1997). We also
find localization of the active non-muscle myosin light chain at
the intercalated discs of healthy heart sections, but the activity
is enhanced in diseased hearts. Similarly, we find active non-
muscle myosin at the costameres only in diseased hearts.
Because this signal is partially overlapping with a-actinin, it is
possible that the previously described Z-disc signal is in fact
coming from the costameres. NM II-C is only present in small
quantities and its genetic ablation has no obvious effects. Dele-
tion of NM II-B, in contrast, is embryonic lethal at E14.5 and
cardiac myocyte specific knockouts lead to progressive hyper-
trophic cardiomyopathy with disruption of the intercalated discs
(Ma andAdelstein, 2012;Ma et al., 2009; Takeda et al., 2000; Tul-
lio et al., 1997). This suggests a role for NM II-B for myofibrillar
anchorage that is in agreement with the localization of active
non-musclemyosin light chain at the cell edge and at force trans-
duction sites that we find in isolated cardiomyocytes. However,
our data further indicate that NM II-B-generated forces can be
measured by mechanosensitive proteins and shift mechano-
transduction regimes. This indicates that aberrant mechano-
sensing is a contributing factor to cardiac remodeling and, in
the long term, to heart failure. Further, this suggests a future pos-
sibility of pharmacological targeting of non-myofibrillar force
production in cardiac disease to correct dysfunctional mechano-
transduction and reduce the risk of end-stage heart failure.
While our study focuses here on cardiomyocyte rigidity
sensing, co-operation of different myosin isoforms and subtypes
is evident in many cell types and tissues and these motor pro-
teins differ in actin binding, enzymatic activity, as well as their
regulation (Billington et al., 2013; Norstrom et al., 2010; Kovacs
et al., 2007; Kim et al., 2005; Kovacs et al., 2003; Wang et al.,
2003a). Moreover, de-regulation of myosin activities and/or
expression has been associated with a range of diseases
(Newell-Litwa et al., 2015). Therefore, it is likely that comparable
multimodal mechanosensing mechanisms are in place in other
cell types as well, albeit with different dynamics.
The combination of its intrinsic deformability, its role in
signaling, and the positioning at the interface between integrins
and actin put talin in a perfect position to measure subtle
changes in mechanical properties (Yao et al., 2016; Das et al.,
2014; del Rio et al., 2009). Here, the use of molecular tension
sensors allowed us to establish the stiffness-dependent tension
on talin with high temporal resolution. However, in addition to ta-
lin, other proteins have been demonstrated to be stretched by
force and contribute to mechanical signaling as well, including
p130Cas, focal adhesion kinase, and titin, especially the titin ki-
nase domain and titin’s I-band region, including the N2B, N2A,
and PEVK domains, whereby, intriguingly, the stiffness of the
latter can be adjusted through phosphorylation by PKCa (Zhou
et al., 2015; Anderson et al., 2010; Linke, 2008; Puchner et al.,Developmental Cell 44, 326–336, February 5, 2018 333
2008; Sawada et al., 2006). Therefore, it is possible that other
mechanosensitive proteins respond in a similar manner and
indeed atomic force microscopy force extension traces for titin
kinase and talin suggest a similar stiffness of the mechanosensi-
tive domains (del Rio et al., 2009; Puchner et al., 2008). Impor-
tantly, unfolding of mechanosensors can mediate the binding
and targeting of proteins that are not direct mechanosensors,
such as the LIM domain protein PINCH1, which is part of the
ILK-PINCH-Parvin complex at the costamere and the Z disc
and involved in embryonic heart development (Li et al., 2012;
Jani and Schock, 2009). Other cardiac LIM domain proteins
are known to shuttle between the cytoplasm and the nucleus
and act as transcriptional co-activators and therefore could
potentially modify gene expression patterns in response to me-
chanical stimuli (Li et al., 2012; Schiller et al., 2011).
Together our data indicate a finely tuned system that is influ-
enced by mechanical and chemical factors to regulate cardio-
myocyte signaling through non-muscle myosin activity at integ-
rin adhesion sites. Intriguingly, this also highlights the potential
of reducing the impact of cardiac fibrosis by targeting non-myofi-
brillar force production in cardiac disease to modify aberrant
mechanotransduction.STAR+METHODS
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Transforming growth factor beta 1 (TGF-b1, 5 ng/ml) PeproTech Cat# AF-100-21C
Bisindolylmaleimide I (BIS I, used at 500 nM) Sigma Cat# B6292
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EXPERIMENTAL MODEL AND SUBJECT DETAILS
Neonatal Rat Cardiomyocytes
Neonatal rat cardiomyocytes were prepared by a sequential digest method. Newborn rat hearts were dissected into ice-cold ADS
buffer (116mM NaCl, 20mM Hepes, 0.8mM NaH2PO4, 5.6mM Glucose, 5.4 mM KCL, 0.8 mM MgSO4). After hearts settled down
to the bottom, hearts were washed once with ADS buffer. ADS buffer was then removed and hearts were incubated with 5ml enzyme
solution in ADS (ES, 246U Collagenase and 0.6 mg Pancreatin / ml), for 5 min, at 37C under vigorous shaking. Supernatant was dis-
carded. This stepwas followed by 5-6 digests, until hearts were completely digested. Each time 5ml fresh ESwas added to the hearts
and incubated 15min at 37C, under shaking. Hearts were pipetted up and down 30 times using a pasteur pipette. After settling down,
supernatant was transferred into plating medium (65% DMEM, 17% M199, 10% Horse Serum, 5% FCS, 2% Glutamax, 1% Pene-
cillin/Streptamycin (P/S)). Two digests each were combined in one tube with 20ml platingmedium, then cleared through a 100mmcell
strainer and spun down at 1200rpm for 5min at RT, before resuspended in 10ml plating medium. Cells were pooled together and pre-
plated for 90min to enrich the cardiomyocytes. Cardiomyocytes were then plated onto the respective substrates as indicated in the
text or figures. Medium was changed the next day to maintenance medium (77% DMEM, 18% M199, 2% Horse Serum, 2% Gluta-
max, 1% P/S), or serum starvation medium (as above, but excluding the Horse Serum).Developmental Cell 44, 326–336.e1–e3, February 5, 2018 e1
Myocardial Infarction
C57BL6/J mice aged 10-12 weeks were subjected to permanent ligation of the left anterior descending coronary artery (LAD) for
4 weeks. ‘‘Sham’’ groups underwent similar surgery apart from LAD ligation (Sirker et al., 2016). Only female mice were used,
because mortality is higher in male compared to female. All procedures were performed in accordance with the Guidance on the
Operation of the Animals (Scientific Procedures) Act, 1986 (UK Home Office). Frozen sections (6 mm) from the non-infarcted LV
segment were stained with the indicated antibodies.
METHOD DETAILS
Cell Culture, Immunostaining and Microscopy
For immunostaining, cells were fixedwith 4%PFA for 10minutes, permeabilized with 0.2% triton X-100 in PBS for 5minutes, blocked
with 5% BSA in PBS for 1h and stained in the antibody solutions in immunostaining buffer (20 mM Tris, 155 mM NaCl, 2 mM EGTA,
2 mMMgCl2, 1%BSA at pH 7.4) (Iskratsch et al., 2013a). Cells were washed three times for 10 minutes with PBS after each step and
mounted in MOWIOL 4-88 (0.1g/ml in Glycerol/Water/Tris (0.2M, pH8.0) at a ratio of 1/1/2) containing a final concentration of 4%
n-propyl gallate. Live cell imaging and imaging of multiwell plates was performed on an inverted Nikon Eclipse Ti-E microscope
with a Nikon DS-Qi2 sCMOS camera and equipped with a Solent Scientific chamber with temperature and CO2 control. Confocal
microscopy was performed on a Nikon A1R+ inverted microscope with GaAsP Detectors. Imaging of FRET sensors, as well as
DIC imaging of cardiomyocytes, used for cell area measurements after PMA treatment, was performed on an inverted ZEISS
LSM 880 microscope with temperature and CO2 control. Imaging of contraction dynamics on PDMS coated coverslips was per-
formed on a Zeiss Axio Observer.Z1 microscope with dish heater, 100X NA1.4 oil objective, and Andor iXon Ultra camera.
PDMS Substrates and Nanopillars
PDMSpillar (500 nmdiameter, 0.8, 1.3, 1.7 or 2.3 mmheight, 1mmcentre-to-centre) substrateswere prepared by soft lithography from
silicon masters. For fluorescent labelled pillars, CdSeS/ZnS alloyed quantum dots (490nm, Sigma) were spun first on the master 30s
at 10,000rpm with a 150i spin processor (SPS), before the addition of PDMS. PDMS (Sylgard 184, Dow Corning) was mixed thor-
oughly with its curing agent (10:1), degassed, poured over the silicon master, placed upside-down on a plasma-treated coverslip-
dish (Mattek), or coverslip 4-well dishes (Ibidi) and cured at 80C for 2 h. The mould was then removed and the pillars were incubated
with fibronectin for 1h at 37C.
The Stiffness of the pillars was calculated as described by Ghibaudo et al but taking into account substrate warping as described










































Flat PDMS substrates were prepared by spin-coating Sylgard 184, Sylard 527 or mixtures at the Ratios of 1:5, 1:10 and 1:20 with a
150i spin processor (SPS), onto coverslips for western blotting samples, or microscope slides for placing into multiwell plates (Grace
Biolabs). Before spin coating, Sylgard 527 was pre-cured at 70C for 30 minutes with intermitted mixing to achieve a comparable vis-
cosity to the Sylgard 184 mixture.
Rheology
Oscillatory rheology was used to characterise the mechanics of the series of PDMS samples using a TA Discovery HR-3 hybrid
rheometer. The samples were cured in situ at 80C for 2hrs and the gelation was monitored by an oscillating time sweep, withe2 Developmental Cell 44, 326–336.e1–e3, February 5, 2018
an oscillating frequency of 1Hz and an oscillating displacement of 1e-4rads. Once cured the samples were then kept at room
temperature for 5 minutes to cool and were then characterised using an oscillating frequency and stress sweep, and by transient
stress relaxation. The frequency sweeps were performed from 0.1-100Hz at an oscillating displacement of 1e-4rads and the stress
sweepswere performed from 0.1-100Pa at a frequency of 1Hz. Finally stress relaxation was performed using a shear strain of 2%and
a hold time of 300s.
Image Analysis
Pillar displacements were analysed with imageJ, using the NanoTracking plugin. An image of the pillars after removal of the cells with
10x trypsin was taken as reference for the non-displaced pillars. For contraction analysis, pillar displacements from spontaneous
contracting cardiomyocytes were measured for the whole movie, using Matlab. From the data, the maximum displacement (systole)
was compared to the subsequent minimum and to the non-displaced pillars. Noise levels were measured from pillars outside the cell
andwere 20.6±2.6, 16.9±4.5, 26.5±4.9 and 29.8±8.5nm for 0.8, 1.3, 1.7 and 2.3mmpillars, respectively. Therefore, all pillars that were
displaced above 30nm during the movie were taken into account for the analysis. Statistics were calculated between cells. A com-
parable result was obtained when combining all pillar displacements.
For comparison of immunostaining with pillar displacements, a perfect grid was assumed and deviations from the grid were calcu-
lated from pillars outside the cell. For the measurement of line profiles, pillar displacements above the 90th percentile were identified
and amask created. The centre of the cell was marked manually and the line profiles were calculated along a line from the respective
point to the centre.
For analysis of the tension sensor, the linear unmixed channels were processedwith aGaussian blur filter with a radius of 2px, using
ImageJ. A RGB movie was created and registered to align adhesions over the contraction cycle. After registration, channels were
separated and the ratio movie was generated by dividing the RFP by the GFP channel. ROIs were drawn over adhesion areas
and the ratio pixel intensity was measured over the length of the movie. To measure cell edge movements and identify the timing
of systole and diastole, a threshold movie was created from the GFP channel and a ROI at the cell edge was drawn and analysed
using the particle tracker function. Ratio and cell edge data traces were detrended and normalized in Matlab, before calculation
of Pearson correlation coefficient. For comparison of RFP/GFP ratio at systole/diastole, maximum and subsequent minimum peaks
were identified from the cell edge trace and ratio at theminimum (diastole) was divided by the ratio at themaximum (systole). The data
from all peaks over the length of the movie (except first and last, to avoid artefacts from incomplete contractions) was averaged and
statistics were calculated between movies.
Cell area, cell morphology and staining intensity were analysed with cell profiler and a grey scale coded output mask was created,
which was used to crop the images of the individual cells and delete the surroundings. Actin and a-actinin images of single cells were
then analysed for filament alignment using the OrientationJ plugin for ImageJ (Rezakhaniha et al., 2012).
For analysis of sarcomeric shortening and velocity, kymographs were drawn over multiple sarcomeres from the cell edge inwards.
Positions of the Z-discs were located for each timepoint by identifying peaks in the kymograph after Gaussian blurring. Z-disc po-
sitions over time were filtered with a Butterworth filter, before the differences between two Z-discs and the respective shortening
velocity were calculated.
QUANTIFICATION AND STATISTICAL ANALYSIS
Data sets were tested for normal distribution using the Shapiro–Wilk test. All box plots are displayed as median (central line), upper
and lower quartile (box), +/- 1.5 x inter quartile range (whiskers). All n-numbers and statistical tests are indicated in the figure legends.
All statistic tests were performed with Graphpad Prism.Developmental Cell 44, 326–336.e1–e3, February 5, 2018 e3
